logo
Select company
Select metric
$ -43.45MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
19
Sector
17
Industry
18
History
44
$ 0.74Close
$ 0.27 - $ 2.37 52-Week Range
Ticker Information

Ticker

BCAB

Company Name

BIOATLA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BIOATLA INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BCAB - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -43.45M
3/31/2025$ -48.27M
12/31/2024$ -62.42M
9/30/2024$ -84.77M
6/30/2024$ -107.03M
3/31/2024$ -112.06M
12/31/2023$ -104.04M
9/30/2023$ -36.84M
6/30/2023$ -33.6M
3/31/2023$ -26.74M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOATLA INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 234.9M.
  • Over the past 5 years, BIOATLA INC's average CF - Chg. Cash has been $ -19.6M.
  • The median CF - Chg. Cash for BIOATLA INC during this period was $ -36.84M
  • BIOATLA INC reached its highest CF - Chg. Cash over the past 5 years at $ 234.9M.
  • The lowest CF - Chg. Cash recorded by BIOATLA INC in the same timeframe $ -112.06M

BIOATLA INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
CRIS : CURIS INC $ 142KCARM : CARISMA THERAPEUTICS INC $ -38.36MCSCIF : COSCIENS BIOPHARMA INC $ -18.47MNXGL : NEXGEL INC $ -344KMRKR : MARKER THERAPEUTICS INC $ 4.01MNRXS : NEURAXIS INC $ 4.22MHCTI : HEALTHCARE TRIANGLE INC $ 3.2MLPCN : LIPOCINE INC $ 490.61KJAGX : JAGUAR HEALTH INC $ -13.84MDYAI : DYADIC INTERNATIONAL INC $ -2.16M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

BCAB - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -112.06M

Minimum

Mar 31, 2024

$ 234.9M

Maximum

Dec 31, 2020

$ -19.6M

Average

$ -36.84M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.19M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.19M
median$ 116.12K
std$ 44.92M